ResMed targets 59-60% gross margins and expanded global reach for AirSense 11
Q2 2025 Management View CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, ...
ResMed: Digital Health Drives Q2 Growth
ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth ...
Sleep Software Market To Hit USD 1,569.2 Million By 2030 With 10.1% CAGR Marketsandmarketstm
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,569.2 Million by 2030.
I got a sleep apnea study in my 30s. It probably saved my life
My wife, who bore the brunt of my transformation into a grumpy badger, was the first to suggest I get a sleep study. She’d ...
生活習慣病リスクと関係がある睡眠時無呼吸の簡易チェックを無料 ...
エムスリーとソニーグループの合弁会社である株式会社サプリム(本社：東京都港区、代表取締役社長：富山泰司、URL ： https://www.sapplym.com/ )の睡眠時無呼吸リスク計測サービス「Sleep Doc」(URL ： https:/ ...
Can the right pillow really help reduce sleep apnea symptoms? Yes, here's how
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...
ギズモード・ジャパン2 日
薄さ2mmの温熱マットで｢布団の中冷たい問題｣を解決
2024年12月10日の記事を編集して再掲載しています。
ResMed: Fully Valued With Medium-Term Challenges (Rating Downgrade)
ResMed’s stock has surged but faces potential risks from GLP-1 drugs. Find out why RMD stock remains a Hold as investors ...